More on MLYS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-298.5% Growth)
- Ratings (9.1 Score)

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mineralys Therapeutics (NQ:MLYS)
Delayed: 24.63 -0.5 (1.99%)
Prev. Close $25.13  
Open$25.58 
52 Wk High$ 
52 Wk Low$ 
Day High$25.99 
Day Low$24.52 
P/E N/A  
EPS$ 
Volume4,062,205 

Friends, Peers and Foes (?): AZN, BIIB, AMGN, IRON, JNJ (more...)

Jun 17, 2026 09:18 PM Form 4 Mineralys Therapeutics, For: Jun 15 Filed by: Rodman David Malcom
Jun 17, 2026 09:18 PM Form 4 Mineralys Therapeutics, For: Jun 17 Filed by: Karydas Daphne
Jun 17, 2026 04:20 PM Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
Jun 17, 2026 04:16 PM Form 144 Mineralys Therapeutics, Filed by: Karydas Daphne
Jun 15, 2026 04:58 PM Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
Jun 14, 2026 02:01 PM Mineralys presents heart failure biomarker data for lorundrostat at ENDO 2026
Jun 14, 2026 10:00 AM Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
Jun 12, 2026 06:05 PM Form 4 Mineralys Therapeutics, For: Jun 10 Filed by: Rodman David Malcom
Jun 12, 2026 04:17 PM Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
Jun 10, 2026 04:12 PM Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
View All Articles

Entities mentioned with MLYS

View All Entities